Making Strides: New Approaches to Metastatic Bladder Cancer
Experts from The Tisch Cancer Institute at Mount Sinai in New York City examine the complexities of treating metastatic bladder cancer and the important role that immunotherapy now plays.
Related Articles
Obesity Therapies: What Will the Future Bring?
Comprehensive outcome measures, combination therapies, and cause-based treatments are on the horizon.
Beyond Scope Creep: Why Physicians and PAs Should Come Together for Patients
Rather than compete, physicians and PAs should be working together to improve access to care and patient outcomes.
ED Syphilis Screening Boosts Surveillance, Diagnoses
The program modeled on HIV screening uses opt-out screening to simplify testing and avoid bias.
Are Genes Responsible for Causing Psoriasis?
Research on the role that genes play in psoriasis has led to targeted therapies to reduce symptoms and slow disease progression.
A New Way to ‘Smuggle’ Drugs Through the Blood-Brain Barrier
Researchers created a noninvasive method to deliver drugs to the hippocampus, showing potential for new Alzheimer’s treatment.
Smartphone Data Flag Early Dementia Risk in Older Adults
A new study highlights the potential of using smartphone data collected in real-world situations for the early detection of cognitive decline in older adults.
Beta Blockers Post-MI? No for Me, Even After the ABYSS Trial
The need for routine beta blockers post MI in contemporary practice has been questioned but a randomized trial of stopping vs continuing suggested they still…
